MicroRNA profiling and prediction of recurrence/relapse-free survival in stage I lung cancer.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Carcinogenesis

• Publication date

  2012-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/carcin/bgs100PMID 22331473PMCID PMC3334512
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Supplemental table 2

  2014cited by this paper
• Classification of non-small cell lung carcinoma in transthoracic needle specimens using microRNA expression profiling.

  2011cited by this paper
• Abstract 2350: MicroRNA-145 suppresses cell invasion and metastasis by directly targeting mucin 1

  2010cited by this paper
• Gene expression-based prognostic signatures in lung cancer: ready for clinical use?

  2010cited by this paper
• MicroRNA-31 functions as an oncogenic microRNA in mouse and human lung cancer cells by repressing specific tumor suppressors.

  2010cited by this paper
• Evaluation of microRNA expression profiles that may predict recurrence of localized stage I non-small cell lung cancer after surgical resection.

  2010cited by this paper
• MicroRNA Expression Differentiates Histology and Predicts Survival of Lung Cancer

  2010cited by this paper
• MiR-218 Inhibits Invasion and Metastasis of Gastric Cancer by Targeting the Robo1 Receptor

  2010cited by this paper
• MicroRNA classifiers for predicting prognosis of squamous cell lung cancer.

  2009cited by this paper
• Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma.

  2009cited by this paper
• A Clinical Model to Estimate Recurrence Risk in Resected Stage I Non-Small Cell Lung Cancer

  2008cited by this paper
• Three-Gene Expression Signature Predicts Survival in Early-Stage Squamous Cell Carcinoma of the Lung

  2008cited by this paper
• Non-overlapping and non-cell-type-specific gene expression signatures predict lung cancer survival.

  2008cited by this paper
• An array-based analysis of microRNA expression comparing matched frozen and formalin-fixed paraffin-embedded human tissue samples.

  2008cited by this paper
• Gene expression–based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study

  2008cited by this paper
• MicroRNA 29c is down-regulated in nasopharyngeal carcinomas, up-regulating mRNAs encoding extracellular matrix proteins

  2008cited by this paper
• Gene Expression Signature Predicts Recurrence in Lung Adenocarcinoma

  2007cited by this paper
• A microRNA component of the p53 tumour suppressor network

  2007cited by this paper
• The let-7 microRNA represses cell proliferation pathways in human cells.

  2007cited by this paper
• MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth.

  2007cited by this paper
• Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis.

  2007cited by this paper
• MicroRNA signatures in human cancers

  2006cited by this paper
• Expression profiling defines a recurrence signature in lung squamous cell carcinoma.

  2006cited by this paper
• Unique microRNA molecular profiles in lung cancer diagnosis and prognosis.

  2006cited by this paper
• COSMIC 2005

  2006cited by this paper
• A Gene Expression Signature Predicts Survival of Patients with Stage I Non-Small Cell Lung Cancer

  2006cited by this paper
• Robust estimation of the false discovery rate

  2006cited by this paper
• Constructing Molecular Classifiers for the Accurate Prognosis of Lung Adenocarcinoma

  2006cited by this paper
• RAS is regulated by the let-7 microRNA family.

  2005cited by this paper
• Expression of syndecan‐1 and expression of epidermal growth factor receptor are associated with survival in patients with nonsmall cell lung carcinoma

  2004cited by this paper
• Partial Cox regression analysis for high-dimensional microarray gene expression data

  2004cited by this paper
• Protein profiles associated with survival in lung adenocarcinoma

  2003cited by this paper
• BRAF and RAS mutations in human lung cancer and melanoma.

  2002cited by this paper
• Brain metastasis model in athymic nude mice using a novel MUC1‐secreting human breast‐cancer cell line, MA11

  1996cited by this paper

• Role of the TLR signaling pathway in the pathogenesis of glioblastoma multiforme with an emphasis on immunotherapy

  2025cites this paper
• Brain metastasis in non‐small cell lung cancer: High‐risk factors and predictive models

  2025cites this paper
• The complex clinical challenges of secondary ovarian tumors and cancer of unknown primary: diagnostic and therapeutic considerations

  2025cites this paper
• Exosomal non-coding rnas as potential biomarkers in the diagnosis and prognosis of lung cancer. Review

  2024cites this paper
• The role of microRNAs in brain metastasis

  2024cites this paper
• Non-invasive discrimination of adenocarcinoma and squamous cell carcinoma based on differential expression of miR-944 and miR-326 in sputum samples of lung cancer patients

  2024cites this paper
• Role of MicroRNA-502-3p in Human Diseases

  2023cites this paper
• Advances in the Molecular Landscape of Lung Cancer Brain Metastasis

  2023cites this paper
• A review of recent advances in the molecular mechanisms underlying brain metastasis in lung cancer.

  2023cites this paper
• miRNA-Seq Tissue Diagnostic Signature: A Novel Model for NSCLC Subtyping

  2023cites this paper
• 非小细胞肺癌脑转移高危因素研究进展

  2022cites this paper
• Epigenetics and precision medicine in lung cancer

  2022cites this paper
• Improved Genotype-Guided Deep Radiomics Signatures for Recurrence Prediction of Non-Small Cell Lung Cancer

  2021influential citation
• Molecular Markers to Predict Prognosis and Treatment Response in Uterine Cervical Cancer

  2021cites this paper
• Exploring the ‘Dormancy Activation Switch’ in the Tumour Microenvironment for Metastatic Lung Cancer: The Possible Role of MicroRNA

  2021cites this paper
• MiR-1307: A comprehensive review of its role in various cancer

  2021cites this paper
• Identifying Drug Resistant miRNAs Using Entropy Based Ranking

  2021cites this paper
• Prognosis of Different Types of Non-Small Cell Lung Cancer Progression: Current State and Perspectives.

  2021cites this paper
• Genotype-Guided Radiomics Signatures for Recurrence Prediction of Non-Small Cell Lung Cancer

  2021cites this paper
• The high expression of miR-31 in lung adenocarcinoma inhibits the malignancy of lung adenocarcinoma tumor stem cells

  2021cites this paper
• Cancer driver gene and non-coding RNA alterations as biomarkers of brain metastasis in lung cancer: A review of the literature.

  2021cites this paper
• Relapse-Related Molecular Signature in early stage Lung Adenocarcinomas based on BER, STING pathway and TILs.

  2020cites this paper
• Multimodal Fusion of Imaging and Genomics for Lung Cancer Recurrence Prediction

  2020cites this paper
• Microarray analysis of the expression profile of immune-related gene in rapid recurrence early-stage lung adenocarcinoma

  2020cites this paper
• Integrating circulating miRNA analysis in the clinical management of lung cancer: Present or future?

  2020cites this paper
• Relapse‐related molecular signature in early‐stage lung adenocarcinomas based on base excision repair, stimulator of interferon genes pathway and tumor‐infiltrating lymphocytes

  2020cites this paper
• A Circle RNA Regulatory Axis Promotes Lung Squamous Metastasis via CDR1-Mediated Regulation of Golgi Trafficking

  2020influential citation
• Decision tree-based classifiers for lung cancer diagnosis and subtyping using TCGA miRNA expression data.

  2019cites this paper
• Global Epidemiology of Lung Cancer

  2019cites this paper
• Roles of exosomes in the carcinogenesis and clinical therapy of non-small cell lung cancer.

  2019cites this paper
• HLA-DQB1 expression on tumor cells is a novel favorable prognostic factor for relapse in early-stage lung adenocarcinoma

  2019cites this paper
• MicroRNA-664 suppresses the growth of cervical cancer cells via targeting c-Kit

  2019cites this paper
• MicroRNA-664 suppresses the growth of cervical cancer cells via targeting c-Kit

  2019cites this paper
• Distinct Molecular Mechanisms Analysis of Three Lung Cancer Subtypes Based on Gene Expression Profiles

  2019cites this paper
• Genetic variations in miR‐125 family and the survival of non‐small cell lung cancer in Chinese population

  2019cites this paper
• The Essential Role of DCLK1 in Pathogenesis, Diagnostic Procedures and Prognostic Stratification of Colorectal Cancer

  2019cites this paper
• MicroRNA-664 functions as an oncogene in cutaneous squamous cell carcinomas (cSCC) via suppressing interferon regulatory factor 2.

  2019cites this paper
• Screening for brain metastases in patients with stage III non-small-cell lung cancer, magnetic resonance imaging or computed tomography? A prospective study.

  2019cites this paper
• HLA-DQB1 expression on tumor cells is a novel favorable prognostic factor for relapse in early-stage lung adenocarcinoma

  2019cites this paper
• Exosomal miRNAs as Novel Pharmacodynamic Biomarkers for Cancer Chemopreventive Agent Early Stage Treatments in Chemically Induced Mouse Model of Lung Squamous Cell Carcinoma

  2019cites this paper
• MicroRNA in Lung Cancer Metastasis

  2019cites this paper
• Identification of recurrence-associated microRNAs in stage I lung adenocarcinoma

  2018cites this paper
• Impact of dietary compounds on cancer-related gut microbiota and microRNA

  2018cites this paper
• Predicting microRNA-disease associations using label propagation based on linear neighborhood similarity

  2018cites this paper
• miR-145 suppresses the proliferation, invasion and migration of NSCLC cells by regulating the BAX/BCL-2 ratio and the caspase-3 cascade

  2018cites this paper
• lncRNA Gm15290 promotes cell proliferation and invasion in lung cancer through directly interacting with and suppressing the tumor suppressor miR-615-5p

  2018cites this paper
• HDAC-Linked “Proliferative” miRNA Expression Pattern in Pancreatic Neuroendocrine Tumors

  2018cites this paper
• MiR-205 as a promising biomarker in the diagnosis and prognosis of lung cancer

  2017cites this paper
• Predicting MicroRNA-Disease Associations Using Network Topological Similarity Based on DeepWalk

  2017cites this paper
• Predicting MicroRNA-Disease Associations Using Kronecker Regularized Least Squares Based on Heterogeneous Omics Data

  2017cites this paper
• Down-regulated microRNA-375 expression as a predictive biomarker in non-small cell lung cancer brain metastasis and its prognostic significance.

  2017cites this paper
• Circulating cell-free microRNAs as clinical cancer biomarkers.

  2017cites this paper
• The pathogenesis, diagnosis, and management of metastatic tumors to the ovary: a comprehensive review

  2017cites this paper
• microRNAs Expression as Novel Genetic Biomarker for Early Prediction and Continuous Monitoring in Pulmonary Cancer

  2017cites this paper
• Lung cancer-associated brain metastasis: Molecular mechanisms and therapeutic options

  2017cites this paper
• XRN2 promotes EMT and metastasis through regulating maturation of miR-10a

  2017cites this paper
• microRNA-664 enhances proliferation, migration and invasion of lung cancer cells.

  2017cites this paper
• Circulating cell-free microRNAs as clinical cancer biomarkers

  2017cites this paper
• MiR-629 promotes human pancreatic cancer progression by targeting FOXO3

  2017cites this paper
• Brain metastases in lung cancer patients : unraveling clinical questions

  2016cites this paper
• miRNA-21 as a novel therapeutic target in lung cancer

  2016cites this paper
• Overexpression of CD44 is associated with the occurrence and migration of non-small cell lung cancer

  2016cites this paper
• A serum microRNA signature as a prognostic factor for patients with advanced NSCLC and its association with tissue microRNA expression profiles

  2016cites this paper
• The pri-let-7a-2 rs1143770C>T is associated with prognosis of surgically resected non-small cell lung cancer.

  2016cites this paper
• Pathobiology of Brain Metastases: Molecular Mechanisms

  2016cites this paper
• Prognostic value of 5-microRNA based signature in T2-T3N0 colon cancer

  2016cites this paper
• MicroRNA-profiles in lung adenocarcinomas

  2016cites this paper
• MicroRNA Deregulation in Lung Cancer and Their Use as Clinical Tools

  2016cites this paper
• MiRNAs: regulators of human disease.

  2016cites this paper
• Comparison of microRNA expression levels between primary and recurrent breast cancer : microRNA-133 a , microRNA-191 , and microRNA-204 can predict local recurrence of breast cancer

  2016cites this paper
• Survival of Patients with Gastrointestinal Cancers Can Be Predicted by a Surrogate microRNA Signature for Cancer Stem-like Cells Marked by DCLK1 Kinase.

  2016cites this paper
• The expression of microRNA-34a is inversely correlated with c-MET and CDK6 and has a prognostic significance in lung adenocarcinoma patients

  2015cites this paper
• miR-377-dependent BCL-xL regulation drives chemotherapeutic resistance in B-cell lymphoid malignancies

  2015cites this paper
• MiR-205 and MiR-375 MicroRNA Assays to Distinguish Squamous Cell Carcinoma from Adenocarcinoma in Lung Cancer Biopsies

  2015cites this paper
• MicroRNA signatures as clinical biomarkers in lung cancer

  2015cites this paper
• miR-5100 promotes tumor growth in lung cancer by targeting Rab6.

  2015cites this paper
• Inflammaging and Cancer: A Challenge for the Mediterranean Diet

  2015cites this paper
• Down-regulation of miR-675-5p contributes to tumor progression and development by targeting pro-tumorigenic GPR55 in non-small cell lung cancer

  2015cites this paper
• MicroRNA-145 Suppresses Osteosarcoma Metastasis via Targeting MMP16

  2015cites this paper
• An integrated genome-wide approach to discover deregulated microRNAs in non-small cell lung cancer: Clinical significance of miR-23b-3p deregulation

  2015cites this paper
• Reactivation of epigenetically silenced miR-512 and miR-373 sensitizes lung cancer cells to cisplatin and restricts tumor growth

  2015cites this paper
• MicroRNAs in Lung Cancer and Lung Cancer Bone Metastases: Biomarkers for Early Diagnosis and Targets for Treatment.

  2015cites this paper
• MicroRNA let-7: Regulation, single nucleotide polymorphism, and therapy in lung cancer.

  2015cites this paper
• Personalized treatment of early-stage non-small-cell lung cancer: the challenging role of EGFR inhibitors.

  2015cites this paper
• miRNA Analysis by Next-Generation Sequencing and its Prognostic Importance in Non-Small Cell Lung Cancer

  2015cites this paper
• MicroRNAs as a Biomarker in Tuberculosis

  2015cites this paper
• Circulating MicroRNAs as Biomarkers

  2015cites this paper
• The identification of microRNAs to predict glioma prognosis

  2015cites this paper
• MicroRNAs in lung cancer

  2014cites this paper
• Prognostic value of microRNA expression in operable non-small cell lung cancer patients

  2014influential citation
• Smoking status impacts microRNA mediated prognosis and lung adenocarcinoma biology

  2014cites this paper
• Predictive Biomarkers and Personalized Medicine Association Study of the let-7 miRNA-Complementary Site Variant in the 3 0 Untranslated Region of the KRAS Gene in Stage III Colon Cancer ( NCCTG N 0147 Clinical Trial )

  2014cites this paper
• MicroRNAs-Role in Lung Cancer

  2014cites this paper
• From Cradle to the Grave: Tissue-specific microRNA signatures in detecting clinical progression of diabetes

  2014cites this paper
• MicroRNAs in lung cancer.

  2014cites this paper
• Therapeutic Use of MicroRNAs in Lung Cancer

  2014cites this paper
• Multi-omics characterization of the molecular effects of smoking and chronic inflammation on the lung

  2014cites this paper
• Molecular mechanisms underlying tumorigenesis of non-small cell lung cancer subtypes

  2014cites this paper
• Abnormal activation of the EGFR signaling pathway mediates the downregulation of miR‑145 through the ERK1/2 in non-small cell lung cancer.

  2014cites this paper
• Differences in miRNA Expression in Early Stage Lung Adenocarcinomas that Did and Did Not Relapse

  2014cites this paper